Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 6/2011

01.09.2011 | Original Paper

Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics

verfasst von: Vicente Molina, Carmen Martín, Alejandro Ballesteros, Alba G. Seco de Herrera, Juan Antonio Hernández-Tamames

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

To date, few studies have addressed the relationship between brain structure alterations and responses to atypical antipsychotics in schizophrenia. To this end, in this study, magnetic resonance imaging (MRI) and voxel-based morphometry (VBM) were used to assess the relationship between the brain volumes of gray (GM) and white (WM) matters and the clinical response to risperidone or olanzapine in 30 schizophrenia patients. In comparison with healthy controls, the patients in this study showed a bilateral decrease in the anteromedial cerebellar hemispheres, the rectal gyrus and the insula, together with bilateral increases in GM in the basal ganglia. Both patient groups had a significantly smaller volume of WM in a region encompassing the internal and external capsules as compared to the controls. We found an inverse association between striatal size and the degree of clinical improvement, and a direct association between the degree of insular volume deficit and its improvement. The non-responder patient group showed a significant decrease in their left rectal gyrus as compared with the responder group. This study reveals a pattern of structural alterations in schizophrenia associated with the response to risperidone or olanzapine.
Literatur
1.
Zurück zum Zitat Amador XF, Kirkpatrick B, Buchanan RW, Carpenter WT, Marcinko L, Yale SA (1999) Stability of the diagnosis of deficit syndrome in schizophrenia. Am J Psychiatry 156:637–639PubMed Amador XF, Kirkpatrick B, Buchanan RW, Carpenter WT, Marcinko L, Yale SA (1999) Stability of the diagnosis of deficit syndrome in schizophrenia. Am J Psychiatry 156:637–639PubMed
2.
Zurück zum Zitat Andersson C, Hamer RM, Lawler CP, Mailman RB, Lieberman JA (2002) Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology 27:143–151PubMedCrossRef Andersson C, Hamer RM, Lawler CP, Mailman RB, Lieberman JA (2002) Striatal volume changes in the rat following long-term administration of typical and atypical antipsychotic drugs. Neuropsychopharmacology 27:143–151PubMedCrossRef
3.
Zurück zum Zitat Andreasen NC, Paradiso S, OL DS (1998) “Cognitive dysmetria” as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull 24:203–218PubMed Andreasen NC, Paradiso S, OL DS (1998) “Cognitive dysmetria” as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry? Schizophr Bull 24:203–218PubMed
4.
Zurück zum Zitat Andreasen NC, Pierson R (2008) The role of the cerebellum in schizophrenia. Biol Psychiatry 64:81–88PubMedCrossRef Andreasen NC, Pierson R (2008) The role of the cerebellum in schizophrenia. Biol Psychiatry 64:81–88PubMedCrossRef
5.
6.
Zurück zum Zitat Baare WF, Hulshoff Pol HE, Hijman R, Mali WP, Viergever MA, Kahn RS (1999) Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology. Biol Psychiatry 45:1597–1605PubMedCrossRef Baare WF, Hulshoff Pol HE, Hijman R, Mali WP, Viergever MA, Kahn RS (1999) Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology. Biol Psychiatry 45:1597–1605PubMedCrossRef
7.
Zurück zum Zitat Bilder RM, Wu H, Chakos MH, Bogerts B, Pollack S, Aronowitz J, Ashtari M, Degreef G, Kane JM, Lieberman JA (1994) Cerebral morphometry and clozapine treatment in schizophrenia. J Clin Psychiatry 55(Suppl B):53–56PubMed Bilder RM, Wu H, Chakos MH, Bogerts B, Pollack S, Aronowitz J, Ashtari M, Degreef G, Kane JM, Lieberman JA (1994) Cerebral morphometry and clozapine treatment in schizophrenia. J Clin Psychiatry 55(Suppl B):53–56PubMed
8.
Zurück zum Zitat Buchanan RW, Breier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F, Carpenter WT Jr (1993) Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry 150:59–65PubMed Buchanan RW, Breier A, Kirkpatrick B, Elkashef A, Munson RC, Gellad F, Carpenter WT Jr (1993) Structural abnormalities in deficit and nondeficit schizophrenia. Am J Psychiatry 150:59–65PubMed
9.
Zurück zum Zitat Buchanan RW, Vladar K, Barta PE, Pearlson GD (1998) Structural evaluation of the prefrontal cortex in schizophrenia. Am J Psychiatry 155:1049–1055PubMed Buchanan RW, Vladar K, Barta PE, Pearlson GD (1998) Structural evaluation of the prefrontal cortex in schizophrenia. Am J Psychiatry 155:1049–1055PubMed
10.
Zurück zum Zitat Buchsbaum MS, Shihabuddin L, Brickman AM, Miozzo R, Prikryl R, Shaw R, Davis K (2003) Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr Res 64:53–62PubMedCrossRef Buchsbaum MS, Shihabuddin L, Brickman AM, Miozzo R, Prikryl R, Shaw R, Davis K (2003) Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophr Res 64:53–62PubMedCrossRef
11.
Zurück zum Zitat Corson PW, Nopoulos P, Miller DD, Arndt S, Andreasen NC (1999) Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry 156:1200–1204PubMed Corson PW, Nopoulos P, Miller DD, Arndt S, Andreasen NC (1999) Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics. Am J Psychiatry 156:1200–1204PubMed
12.
Zurück zum Zitat Crespo-Facorro B, Kim J, Andreasen NC, O’Leary DS, Bockholt HJ, Magnotta V (2000) Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients. Schizophr Res 46:35–43PubMedCrossRef Crespo-Facorro B, Kim J, Andreasen NC, O’Leary DS, Bockholt HJ, Magnotta V (2000) Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients. Schizophr Res 46:35–43PubMedCrossRef
13.
Zurück zum Zitat Crespo Facorro B, Paradiso S, Andreasen NC, DS OL, Watkins GL, Boles Ponto LL, Hichwa RD (1999) Recalling word lists reveals “cognitive dysmetria” in schizophrenia: a positron emission tomography study. Am J Psychiatry 156:386–392PubMed Crespo Facorro B, Paradiso S, Andreasen NC, DS OL, Watkins GL, Boles Ponto LL, Hichwa RD (1999) Recalling word lists reveals “cognitive dysmetria” in schizophrenia: a positron emission tomography study. Am J Psychiatry 156:386–392PubMed
14.
Zurück zum Zitat Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, Wu H, Kinon B, Ashtari M (1994) Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 151:1430–1436PubMed Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, Wu H, Kinon B, Ashtari M (1994) Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 151:1430–1436PubMed
15.
Zurück zum Zitat Davatzikos C, Shen D, Gur RC, Wu X, Liu D, Fan Y, Hughett P, Turetsky BI, Gur RE (2005) Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry 62:1218–1227PubMedCrossRef Davatzikos C, Shen D, Gur RC, Wu X, Liu D, Fan Y, Hughett P, Turetsky BI, Gur RE (2005) Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry 62:1218–1227PubMedCrossRef
16.
Zurück zum Zitat Di X, Chan RC, Gong QY (2009) White matter reduction in patients with schizophrenia as revealed by voxel-based morphometry: an activation likelihood estimation meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 33:1390–1394PubMedCrossRef Di X, Chan RC, Gong QY (2009) White matter reduction in patients with schizophrenia as revealed by voxel-based morphometry: an activation likelihood estimation meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 33:1390–1394PubMedCrossRef
17.
Zurück zum Zitat Fornito A, Yucel M, Patti J, Wood SJ, Pantelis C (2009) Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res 108:104–113PubMedCrossRef Fornito A, Yucel M, Patti J, Wood SJ, Pantelis C (2009) Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr Res 108:104–113PubMedCrossRef
18.
Zurück zum Zitat Friedman L, Knutson L, Shurell M, Meltzer HY (1991) Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia. Biol Psychiatry 29:865–877PubMedCrossRef Friedman L, Knutson L, Shurell M, Meltzer HY (1991) Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia. Biol Psychiatry 29:865–877PubMedCrossRef
19.
Zurück zum Zitat Glahn DC, Laird AR, Ellison-Wright I, Thelen SM, Robinson JL, Lancaster JL, Bullmore E, Fox PT (2008) Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 64:774–781PubMedCrossRef Glahn DC, Laird AR, Ellison-Wright I, Thelen SM, Robinson JL, Lancaster JL, Bullmore E, Fox PT (2008) Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 64:774–781PubMedCrossRef
20.
Zurück zum Zitat Glenthoj A, Glenthoj BY, Mackeprang T, Pagsberg AK, Hemmingsen RP, Jernigan TL, Baare WF (2007) Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res 154:199–208PubMedCrossRef Glenthoj A, Glenthoj BY, Mackeprang T, Pagsberg AK, Hemmingsen RP, Jernigan TL, Baare WF (2007) Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res 154:199–208PubMedCrossRef
21.
Zurück zum Zitat Goldstein JM, Goodman JM, Seidman LJ, Kennedy DN, Makris N, Lee H, Tourville J, Caviness VS Jr, Faraone SV, Tsuang MT (1999) Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry 56:537–547PubMedCrossRef Goldstein JM, Goodman JM, Seidman LJ, Kennedy DN, Makris N, Lee H, Tourville J, Caviness VS Jr, Faraone SV, Tsuang MT (1999) Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch Gen Psychiatry 56:537–547PubMedCrossRef
22.
Zurück zum Zitat Gur RE, Cowell PE, Latshaw A, Turetsky BI, Grossman RI, Arnold SE, Bilker WB, Gur RC (2000) Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia [In Process Citation]. Arch Gen Psychiatry 57:761–768PubMedCrossRef Gur RE, Cowell PE, Latshaw A, Turetsky BI, Grossman RI, Arnold SE, Bilker WB, Gur RC (2000) Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia [In Process Citation]. Arch Gen Psychiatry 57:761–768PubMedCrossRef
23.
Zurück zum Zitat Harvey I, Ron MA, Du Boulay G, Wicks D, Lewis SW, Murray RM (1993) Reduction of cortical volume in schizophrenia on magnetic resonance imaging. Psychol Med 23:591–604PubMedCrossRef Harvey I, Ron MA, Du Boulay G, Wicks D, Lewis SW, Murray RM (1993) Reduction of cortical volume in schizophrenia on magnetic resonance imaging. Psychol Med 23:591–604PubMedCrossRef
24.
Zurück zum Zitat Ho BC, Alicata D, Mola C, Andreasen NC (2005) Hippocampus volume and treatment delays in first-episode schizophrenia. Am J psychiatry 162:1527–1529PubMedCrossRef Ho BC, Alicata D, Mola C, Andreasen NC (2005) Hippocampus volume and treatment delays in first-episode schizophrenia. Am J psychiatry 162:1527–1529PubMedCrossRef
25.
Zurück zum Zitat Hulshoff Pol HE, Schnack HG, Mandl RC, van Haren NE, Koning H, Collins DL, Evans AC, Kahn RS (2001) Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry 58:1118–1125PubMedCrossRef Hulshoff Pol HE, Schnack HG, Mandl RC, van Haren NE, Koning H, Collins DL, Evans AC, Kahn RS (2001) Focal gray matter density changes in schizophrenia. Arch Gen Psychiatry 58:1118–1125PubMedCrossRef
26.
Zurück zum Zitat Kasai K, Shenton ME, Salisbury DF, Onitsuka T, Toner SK, Yurgelun-Todd D, Kikinis R, Jolesz FA, McCarley RW (2003) Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosis. Arch Gen Psychiatry 60:1069–1077PubMedCrossRef Kasai K, Shenton ME, Salisbury DF, Onitsuka T, Toner SK, Yurgelun-Todd D, Kikinis R, Jolesz FA, McCarley RW (2003) Differences and similarities in insular and temporal pole MRI gray matter volume abnormalities in first-episode schizophrenia and affective psychosis. Arch Gen Psychiatry 60:1069–1077PubMedCrossRef
27.
Zurück zum Zitat Kasper S, Hale A, Azorin JM, Moller HJ (1999) Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia. Eur Arch Psychiatry Clin Neurosci 249(Suppl 2):II1–II14PubMed Kasper S, Hale A, Azorin JM, Moller HJ (1999) Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia. Eur Arch Psychiatry Clin Neurosci 249(Suppl 2):II1–II14PubMed
28.
Zurück zum Zitat Kawasaki Y, Suzuki M, Nohara S, Hagino H, Takahashi T, Matsui M, Yamashita I, Chitnis XA, McGuire PK, Seto H, Kurachi M (2004) Structural brain differences in patients with schizophrenia and schizotypal disorder demonstrated by voxel-based morphometry. Eur Arch Psychiatry Clin Neurosci 254:406–414PubMedCrossRef Kawasaki Y, Suzuki M, Nohara S, Hagino H, Takahashi T, Matsui M, Yamashita I, Chitnis XA, McGuire PK, Seto H, Kurachi M (2004) Structural brain differences in patients with schizophrenia and schizotypal disorder demonstrated by voxel-based morphometry. Eur Arch Psychiatry Clin Neurosci 254:406–414PubMedCrossRef
29.
Zurück zum Zitat JLt Knoll, Garver DL, Ramberg JE, Kingsbury SJ, Croissant D, McDermott B (1998) Heterogeneity of the psychoses: is there a neurodegenerative psychosis? Schizophr Bull 24:365–379 JLt Knoll, Garver DL, Ramberg JE, Kingsbury SJ, Croissant D, McDermott B (1998) Heterogeneity of the psychoses: is there a neurodegenerative psychosis? Schizophr Bull 24:365–379
30.
Zurück zum Zitat Kubicki M, Shenton ME, Salisbury DF, Hirayasu Y, Kasai K, Kikinis R, Jolesz FA, McCarley RW (2002) Voxel-based morphometric analysis of gray matter in first episode schizophrenia. Neuroimage 17:1711–1719PubMedCrossRef Kubicki M, Shenton ME, Salisbury DF, Hirayasu Y, Kasai K, Kikinis R, Jolesz FA, McCarley RW (2002) Voxel-based morphometric analysis of gray matter in first episode schizophrenia. Neuroimage 17:1711–1719PubMedCrossRef
31.
Zurück zum Zitat Kumari V, Fannon D, Geyer MA, Premkumar P, Antonova E, Simmons A, Kuipers E (2008) Cortical grey matter volume and sensorimotor gating in schizophrenia. Cortex 44:1206–1214PubMedCrossRef Kumari V, Fannon D, Geyer MA, Premkumar P, Antonova E, Simmons A, Kuipers E (2008) Cortical grey matter volume and sensorimotor gating in schizophrenia. Cortex 44:1206–1214PubMedCrossRef
32.
Zurück zum Zitat Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, Honer WG (2001) An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. Am J Psychiatry 158:625–631PubMedCrossRef Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, Honer WG (2001) An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone. Am J Psychiatry 158:625–631PubMedCrossRef
33.
Zurück zum Zitat Lauriello J, Mathalon DH, Rosenbloom M, Sullivan EV, Faustman WO, Ringo DL, Lim KO, Pfefferbaum A (1998) Association between regional brain volumes and clozapine response in schizophrenia. Biol Psychiatry 43:879–886PubMedCrossRef Lauriello J, Mathalon DH, Rosenbloom M, Sullivan EV, Faustman WO, Ringo DL, Lim KO, Pfefferbaum A (1998) Association between regional brain volumes and clozapine response in schizophrenia. Biol Psychiatry 43:879–886PubMedCrossRef
34.
Zurück zum Zitat Lieberman JA (1999) Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 46:729–739PubMedCrossRef Lieberman JA (1999) Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 46:729–739PubMedCrossRef
35.
Zurück zum Zitat Lieberman JA, Alvir JM, Koreen A, Geisler S, Chakos M, Sheitman B, Woerner M (1996) Psychobiologic correlates of treatment response in schizophrenia. Neuropsychopharmacology 14:13S–21SPubMedCrossRef Lieberman JA, Alvir JM, Koreen A, Geisler S, Chakos M, Sheitman B, Woerner M (1996) Psychobiologic correlates of treatment response in schizophrenia. Neuropsychopharmacology 14:13S–21SPubMedCrossRef
36.
Zurück zum Zitat Makris N, Goldstein JM, Kennedy D, Hodge SM, Caviness VS, Faraone SV, Tsuang MT, Seidman LJ (2006) Decreased volume of left and total anterior insular lobule in schizophrenia. Schizophr Res 83:155–171PubMedCrossRef Makris N, Goldstein JM, Kennedy D, Hodge SM, Caviness VS, Faraone SV, Tsuang MT, Seidman LJ (2006) Decreased volume of left and total anterior insular lobule in schizophrenia. Schizophr Res 83:155–171PubMedCrossRef
37.
Zurück zum Zitat McDonald C, Bullmore E, Sham P, Chitnis X, Suckling J, MacCabe J, Walshe M, Murray RM (2005) Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study. Br J Psychiatry 186:369–377PubMedCrossRef McDonald C, Bullmore E, Sham P, Chitnis X, Suckling J, MacCabe J, Walshe M, Murray RM (2005) Regional volume deviations of brain structure in schizophrenia and psychotic bipolar disorder: computational morphometry study. Br J Psychiatry 186:369–377PubMedCrossRef
38.
Zurück zum Zitat Meisenzahl EM, Koutsouleris N, Bottlender R, Scheuerecker J, Jager M, Teipel SJ, Holzinger S, Frodl T, Preuss U, Schmitt G, Burgermeister B, Reiser M, Born C, Moller HJ (2008) Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study. Schizophr Res 104:44–60PubMedCrossRef Meisenzahl EM, Koutsouleris N, Bottlender R, Scheuerecker J, Jager M, Teipel SJ, Holzinger S, Frodl T, Preuss U, Schmitt G, Burgermeister B, Reiser M, Born C, Moller HJ (2008) Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study. Schizophr Res 104:44–60PubMedCrossRef
39.
Zurück zum Zitat Mitelman SA, Canfield EL, Chu KW, Brickman AM, Shihabuddin L, Hazlett EA, Buchsbaum MS (2009) Poor outcome in chronic schizophrenia is associated with progressive loss of volume of the putamen. Schizophr Res 113:241–245PubMedCrossRef Mitelman SA, Canfield EL, Chu KW, Brickman AM, Shihabuddin L, Hazlett EA, Buchsbaum MS (2009) Poor outcome in chronic schizophrenia is associated with progressive loss of volume of the putamen. Schizophr Res 113:241–245PubMedCrossRef
40.
Zurück zum Zitat Mitelman SA, Nikiforova YK, Canfield EL, Hazlett EA, Brickman AM, Shihabuddin L, Buchsbaum MS (2009) A longitudinal study of the corpus callosum in chronic schizophrenia. Schizophrenia Res 114:144–153CrossRef Mitelman SA, Nikiforova YK, Canfield EL, Hazlett EA, Brickman AM, Shihabuddin L, Buchsbaum MS (2009) A longitudinal study of the corpus callosum in chronic schizophrenia. Schizophrenia Res 114:144–153CrossRef
41.
Zurück zum Zitat Molina V, Hernández JA, Sanz J, Paniagua JC, Hernádez AI, Martín C, Matías J, Calama J, Bote B (in press) Subcortical and cortical gray matter differences between kraepelinian and non kraepelinian schizophrenia patients identified using voxel-based morphometry. Psychiatry Res Neuroimaging Molina V, Hernández JA, Sanz J, Paniagua JC, Hernádez AI, Martín C, Matías J, Calama J, Bote B (in press) Subcortical and cortical gray matter differences between kraepelinian and non kraepelinian schizophrenia patients identified using voxel-based morphometry. Psychiatry Res Neuroimaging
42.
Zurück zum Zitat Molina V, Reig S, Pascau J, Sanz J, Sarramea F, Gispert JD, Luque R, Benito C, Palomo T, Desco M (2003) Anatomical and functional variables associated with basal symptoms but not to risperidone response in minimally-treated schizophrenia. Psychiatry res Neuroimaging 124:163–175CrossRef Molina V, Reig S, Pascau J, Sanz J, Sarramea F, Gispert JD, Luque R, Benito C, Palomo T, Desco M (2003) Anatomical and functional variables associated with basal symptoms but not to risperidone response in minimally-treated schizophrenia. Psychiatry res Neuroimaging 124:163–175CrossRef
43.
Zurück zum Zitat Molina V, Reig S, Sarramea F, Sanz J, F Artaloytia J, Luque R, Aragüés M, Pascau J, Benito C, Palomo T, Desco M (2003) Anatomical and functional brain variables associated to clozapine response in treatment-resistant schizophrenia. Psychiatry Res Neuroimaging 124:153–161CrossRef Molina V, Reig S, Sarramea F, Sanz J, F Artaloytia J, Luque R, Aragüés M, Pascau J, Benito C, Palomo T, Desco M (2003) Anatomical and functional brain variables associated to clozapine response in treatment-resistant schizophrenia. Psychiatry Res Neuroimaging 124:153–161CrossRef
44.
Zurück zum Zitat Molina V, Sanz J, Benito C, Palomo T (2004) Direct association between orbitofrontal atrophy and the response of psychotic symptoms to olanzapine in schizophrenia. Int Clin Psychopharmacol 19:221–228PubMedCrossRef Molina V, Sanz J, Benito C, Palomo T (2004) Direct association between orbitofrontal atrophy and the response of psychotic symptoms to olanzapine in schizophrenia. Int Clin Psychopharmacol 19:221–228PubMedCrossRef
45.
Zurück zum Zitat Nopoulos PC, Ceilley JW, Gailis EA, Andreasen NC (1999) An MRI study of cerebellar vermis morphology in patients with schizophrenia: evidence in support of the cognitive dysmetria concept. Biol Psychiatry 46:703–711PubMedCrossRef Nopoulos PC, Ceilley JW, Gailis EA, Andreasen NC (1999) An MRI study of cerebellar vermis morphology in patients with schizophrenia: evidence in support of the cognitive dysmetria concept. Biol Psychiatry 46:703–711PubMedCrossRef
46.
Zurück zum Zitat Oh JS, Kubicki M, Rosenberger G, Bouix S, Levitt JJ, McCarley RW, Westin CF, Shenton ME (2009) Thalamo-frontal white matter alterations in chronic schizophrenia: a quantitative diffusion tractography study. Hum Brain Mapp 30:3812–3825PubMedCrossRef Oh JS, Kubicki M, Rosenberger G, Bouix S, Levitt JJ, McCarley RW, Westin CF, Shenton ME (2009) Thalamo-frontal white matter alterations in chronic schizophrenia: a quantitative diffusion tractography study. Hum Brain Mapp 30:3812–3825PubMedCrossRef
47.
Zurück zum Zitat Okugawa G, Sedvall G, Nordstrom M, Andreasen N, Pierson R, Magnotta V, Agartz I (2002) Selective reduction of the posterior superior vermis in men with chronic schizophrenia. Schizophr Res 55:61–67PubMedCrossRef Okugawa G, Sedvall G, Nordstrom M, Andreasen N, Pierson R, Magnotta V, Agartz I (2002) Selective reduction of the posterior superior vermis in men with chronic schizophrenia. Schizophr Res 55:61–67PubMedCrossRef
48.
Zurück zum Zitat Savas HA, Unal B, Erbagci H, Inaloz S, Herken H, Canan S, Gumusburun E, Zoroglu SS (2002) Hippocampal volume in schizophrenia and its relationship with risperidone treatment: a stereological study. Neuropsychobiology 46:61–66PubMedCrossRef Savas HA, Unal B, Erbagci H, Inaloz S, Herken H, Canan S, Gumusburun E, Zoroglu SS (2002) Hippocampal volume in schizophrenia and its relationship with risperidone treatment: a stereological study. Neuropsychobiology 46:61–66PubMedCrossRef
49.
Zurück zum Zitat Scheepers FE, de Wied CC, Hulshoff Pol HE, van de Flier W, van der Linden JA, Kahn RS (2001) The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics. Neuropsychopharmacology 24:47–54PubMedCrossRef Scheepers FE, de Wied CC, Hulshoff Pol HE, van de Flier W, van der Linden JA, Kahn RS (2001) The effect of clozapine on caudate nucleus volume in schizophrenic patients previously treated with typical antipsychotics. Neuropsychopharmacology 24:47–54PubMedCrossRef
50.
Zurück zum Zitat Schobel SA, Kelly MA, Corcoran CM, Van Heertum K, Seckinger R, Goetz R, Harkavy-Friedman J, Malaspina D (2009) Anterior hippocampal and orbitofrontal cortical structural brain abnormalities in association with cognitive deficits in schizophrenia. Schizophr Res 114:110–118PubMedCrossRef Schobel SA, Kelly MA, Corcoran CM, Van Heertum K, Seckinger R, Goetz R, Harkavy-Friedman J, Malaspina D (2009) Anterior hippocampal and orbitofrontal cortical structural brain abnormalities in association with cognitive deficits in schizophrenia. Schizophr Res 114:110–118PubMedCrossRef
51.
Zurück zum Zitat Takahashi T, Wood SJ, Soulsby B, McGorry PD, Tanino R, Suzuki M, Velakoulis D, Pantelis C (2009) Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia. Schizophr Res 108:49–56PubMedCrossRef Takahashi T, Wood SJ, Soulsby B, McGorry PD, Tanino R, Suzuki M, Velakoulis D, Pantelis C (2009) Follow-up MRI study of the insular cortex in first-episode psychosis and chronic schizophrenia. Schizophr Res 108:49–56PubMedCrossRef
52.
Zurück zum Zitat Tamagaki C, Sedvall GC, Jonsson EG, Okugawa G, Hall H, Pauli S, Agartz I (2005) Altered white matter/gray matter proportions in the striatum of patients with schizophrenia: a volumetric MRI study. Am J Psychiatry 162:2315–2321PubMedCrossRef Tamagaki C, Sedvall GC, Jonsson EG, Okugawa G, Hall H, Pauli S, Agartz I (2005) Altered white matter/gray matter proportions in the striatum of patients with schizophrenia: a volumetric MRI study. Am J Psychiatry 162:2315–2321PubMedCrossRef
53.
Zurück zum Zitat Tran KD, Smutzer GS, Doty RL, Arnold SE (1998) Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. Am J Psychiatry 155:1288–1290PubMed Tran KD, Smutzer GS, Doty RL, Arnold SE (1998) Reduced Purkinje cell size in the cerebellar vermis of elderly patients with schizophrenia. Am J Psychiatry 155:1288–1290PubMed
54.
Zurück zum Zitat Wassink TH, Andreasen NC, Nopoulos P, Flaum M (1999) Cerebellar morphology as a predictor of symptom and psychosocial outcome in schizophrenia. Biol Psychiatry 45:41–48PubMedCrossRef Wassink TH, Andreasen NC, Nopoulos P, Flaum M (1999) Cerebellar morphology as a predictor of symptom and psychosocial outcome in schizophrenia. Biol Psychiatry 45:41–48PubMedCrossRef
55.
Zurück zum Zitat Wobrock T, Gruber O, Schneider-Axmann T, Wolwer W, Gaebel W, Riesbeck M, Maier W, Klosterkotter J, Schneider F, Buchkremer G, Moller HJ, Schmitt A, Bender S, Schlosser R, Falkai P (2009) Internal capsule size associated with outcome in first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci 259:278–283PubMedCrossRef Wobrock T, Gruber O, Schneider-Axmann T, Wolwer W, Gaebel W, Riesbeck M, Maier W, Klosterkotter J, Schneider F, Buchkremer G, Moller HJ, Schmitt A, Bender S, Schlosser R, Falkai P (2009) Internal capsule size associated with outcome in first-episode schizophrenia. Eur Arch Psychiatry Clin Neurosci 259:278–283PubMedCrossRef
56.
Zurück zum Zitat Wright IC, Ellison ZR, Sharma T, Friston KJ, Murray RM, McGuire PK (1999) Mapping of grey matter changes in schizophrenia. Schizophr Res 35:1–14PubMedCrossRef Wright IC, Ellison ZR, Sharma T, Friston KJ, Murray RM, McGuire PK (1999) Mapping of grey matter changes in schizophrenia. Schizophr Res 35:1–14PubMedCrossRef
57.
Zurück zum Zitat Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET (2000) Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157:16–25PubMed Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET (2000) Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157:16–25PubMed
58.
Zurück zum Zitat Yoshihara Y, Sugihara G, Matsumoto H, Suckling J, Nishimura K, Toyoda T, Isoda H, Tsuchiya KJ, Takebayashi K, Suzuki K, Sakahara H, Nakamura K, Mori N, Takei N (2008) Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia. Ann Gen Psychiatry 7:25PubMedCrossRef Yoshihara Y, Sugihara G, Matsumoto H, Suckling J, Nishimura K, Toyoda T, Isoda H, Tsuchiya KJ, Takebayashi K, Suzuki K, Sakahara H, Nakamura K, Mori N, Takei N (2008) Voxel-based structural magnetic resonance imaging (MRI) study of patients with early onset schizophrenia. Ann Gen Psychiatry 7:25PubMedCrossRef
59.
Zurück zum Zitat Zipursky RB, Zhang-Wong J, Lambe EK, Bean G, Beiser M (1998) MRI correlates of treatment response in first episode psychosis. Schizophr Res 30:81–90PubMedCrossRef Zipursky RB, Zhang-Wong J, Lambe EK, Bean G, Beiser M (1998) MRI correlates of treatment response in first episode psychosis. Schizophr Res 30:81–90PubMedCrossRef
Metadaten
Titel
Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics
verfasst von
Vicente Molina
Carmen Martín
Alejandro Ballesteros
Alba G. Seco de Herrera
Juan Antonio Hernández-Tamames
Publikationsdatum
01.09.2011
Verlag
Springer-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 6/2011
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-010-0182-2

Weitere Artikel der Ausgabe 6/2011

European Archives of Psychiatry and Clinical Neuroscience 6/2011 Zur Ausgabe

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.